MedTrace Logo

Gene-STEPS: Shortening Time of Evaluation in Paediatric Epilepsy Services

NCT06082999 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2023-10-13

No results posted yet for this study

Summary

Overall, this observational cohort study aims too:

1. Implement rapid trio WGS for all children presenting to our health systems with epilepsy onset under 12 months of age.
2. Utilize electronic healthcare records and research databases to unite phenotypic and genomic data and to create a "virtual" registry across all institutions that will promote ongoing discovery.
3. Assess the impact of early genetic diagnosis on epilepsy, developmental, and health economic outcomes through formal longitudinal assessments of all children enrolled.

Conditions

Sponsors & Collaborators

  • Murdoch Childrens Research Institute

    collaborator OTHER

  • The Hospital for Sick Children

    collaborator OTHER

  • Boston Children's Hospital

    collaborator OTHER

  • Great Ormond Street Hospital for Children NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Amy McTague · UCL Great Ormond Street Institute of Child Health

Eligibility

Max Age
12 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • United States
  • Australia
  • Canada
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06082999 on ClinicalTrials.gov